Xenon Pharmaceuticals Inc (XENE)
41.09
+1.08
(+2.70%)
USD |
NASDAQ |
Apr 23, 16:00
41.07
-0.02
(-0.05%)
Pre-Market: 20:00
Xenon Pharmaceuticals 1 Year Total Returns (Daily): 4.32% for April 23, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 23, 2024 | 4.32% |
April 22, 2024 | 1.57% |
April 19, 2024 | 4.95% |
April 18, 2024 | 7.35% |
April 17, 2024 | 12.36% |
April 16, 2024 | 16.54% |
April 15, 2024 | 16.04% |
April 12, 2024 | 17.03% |
April 11, 2024 | 22.00% |
April 10, 2024 | 21.79% |
April 09, 2024 | 22.45% |
April 08, 2024 | 21.29% |
April 05, 2024 | 20.99% |
April 04, 2024 | 16.99% |
April 03, 2024 | 12.56% |
April 02, 2024 | 15.87% |
April 01, 2024 | 17.74% |
March 28, 2024 | 24.35% |
March 27, 2024 | 24.85% |
March 26, 2024 | 21.71% |
March 25, 2024 | 21.83% |
March 22, 2024 | 31.15% |
March 21, 2024 | 29.86% |
March 20, 2024 | 26.56% |
March 19, 2024 | 32.03% |
Date | Value |
---|---|
March 18, 2024 | 27.69% |
March 15, 2024 | 29.37% |
March 14, 2024 | 26.62% |
March 13, 2024 | 31.70% |
March 12, 2024 | 29.46% |
March 11, 2024 | 29.81% |
March 08, 2024 | 27.73% |
March 07, 2024 | 28.08% |
March 06, 2024 | 23.78% |
March 05, 2024 | 24.29% |
March 04, 2024 | 24.16% |
March 01, 2024 | 16.08% |
February 29, 2024 | 19.61% |
February 28, 2024 | 21.24% |
February 27, 2024 | 28.24% |
February 26, 2024 | 26.85% |
February 23, 2024 | 29.04% |
February 22, 2024 | 32.79% |
February 21, 2024 | 33.74% |
February 20, 2024 | 26.29% |
February 16, 2024 | 28.00% |
February 15, 2024 | 25.46% |
February 14, 2024 | 22.14% |
February 13, 2024 | 19.31% |
February 12, 2024 | 24.87% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-37.05%
Minimum
Sep 11 2019
242.7%
Maximum
Nov 01 2021
41.72%
Average
31.70%
Median
Mar 13 2024
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 3.23% |
Aurinia Pharmaceuticals Inc | -52.52% |
Edesa Biotech Inc | -40.94% |
Lexaria Bioscience Corp | -1.32% |
ESSA Pharma Inc | 136.3% |